Brainsway (BWAY)
(Real Time Quote from BATS)
$5.91 USD
-0.01 (-0.17%)
Updated Jul 3, 2024 11:24 AM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Brainsway Ltd. Sponsored ADR (BWAY) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.75 | $15.00 | $9.00 | 98.48% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Brainsway Ltd. Sponsored ADR comes to $11.75. The forecasts range from a low of $9.00 to a high of $15.00. The average price target represents an increase of 98.48% from the last closing price of $5.92.
Analyst Price Targets (4 )
Broker Rating
Brainsway Ltd. Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/BWAY.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/9/2024 | LadenburgThalmann | Jeffrey S Cohen | Strong Buy | Strong Buy |
5/8/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/8/2024 | Northland Capital Markets | Carl Byrnes | Strong Buy | Strong Buy |
3/11/2024 | H.C. Wainwright & Co. | Raghuram Selvaraju | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $11.75 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 153 of 252 |
Current Quarter EPS Est: | 0.00 |